Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Century Therapeutics, Inc. (IPSC) is a Biotechnology company based in US with a market capitalization of $193.9M. Revenue grew 1556.8% year-over-year and free cash flow was negative at -$104.7M. This page tracks IPSC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 140 employees · IPO Jun 18, 2021
Valuation
Valuation & price
$2.34as of May 17, 2026· -20.4% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.22
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$193.9M
Market cap
1556.8%
Revenue growth (YoY)
88.0%
Gross margin
-$104.7M
Free cash flow (USD)
-$73.5M
Net debt
Net cash position
10.1%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2022 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
5
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 13, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJun 16, 2026Filing
Employment Agreement Amended
- Insider sellJun 15, 2026Filing
Insider Sell $4KCarr Douglas · SVP Finance & Operations · $3.7K
- Insider sellJun 15, 2026Filing
Insider Sell $6KRussotti Gregory · See Remarks · $5.8K
- 8-K eventJun 12, 2026Filing
Authorized Shares Amendment
- Insider sellJun 9, 2026Filing
Insider Sell $526Carr Douglas · SVP Finance & Operations · $525.6
- Insider sellJun 9, 2026Filing
Insider Sell $1KRussotti Gregory · See Remarks · $1.1K
- 8-K eventJun 8, 2026Filing
Preclinical Research Presentation
- Quarterly reportMay 13, 2026Filing
10-Q Filed
- 8-K eventMay 13, 2026Filing
Earnings Release
- Insider sellMay 6, 2026Filing
Insider Sell $618Carr Douglas · SVP Finance & Operations · $618
Questions
Frequently asked questions
What is Century Therapeutics, Inc.'s market cap?
Century Therapeutics, Inc. (IPSC) has a market capitalization of $193.9M.
What is IPSC's P/E ratio?
A meaningful P/E ratio is not available for IPSC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is IPSC's price-to-book (P/B) ratio?
IPSC trades at 1.22 times book value per share.
Are insiders buying IPSC stock?
SEC Form 4 filings show no open-market insider buys at Century Therapeutics, Inc. in the last 90 days (5 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.